Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
Predicting dopamine agonist resistance in patients with macroprolactinoma is essential for clinicians to prevent treatment failure and subsequent complications such as medication-induced cerebrospinal fluid (CSF) rhinorrhea. We evaluated the features of patients with cabergoline resistance and CSF r...
Guardado en:
Autores principales: | Hae-Kyung Kim, Jae-Won Hong, Ju-Hyung Moon, Sung-Soo Ahn, Eui-Hyun Kim, Seung-Koo Lee, Eun-Jig Lee, Yae-Won Park, Cheol-Ryong Ku |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9510b45db974f3390a6d6e6d2b51516 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reducing the risk of cerebrospinal fluid rhinorrhea following translabyrinthine surgery of the posterior fossa
por: Matthew W. Cooper, et al.
Publicado: (2021) -
Macroprolactinoma en adolescentes: respuesta al tratamiento con bromocriptina
por: Reyes G,Maria Loreto, et al.
Publicado: (1996) -
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Rosa Pirchio, et al.
Publicado: (2021) -
Resultados visuales en pacientes con macroprolactinoma tratados con agonistas de dopamina
por: Cuevas,José Luis, et al.
Publicado: (2013) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Yunzhi Zou, et al.
Publicado: (2021)